| Literature DB >> 12767738 |
Thomas Guttuso1, Joseph Roscoe, Jennifer Griggs.
Abstract
In an anecdotal report, complete resolution of chemotherapy-induced nausea was seen in a patient with breast cancer, after she was placed on the anticonvulsant gabapentin. On this basis, we did an open-label study in which oral gabapentin 300 mg thrice daily was given for every other chemotherapy treatment in nine patients with breast cancer. Six of the nine reported at least a three-point improvement in peak delayed nausea (on an eight-point nausea scale), and three patients had complete resolution of nausea when taking gabapentin. This preliminary evidence shows that gabapentin might have a role in treatment of chemotherapy-induced nausea.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12767738 DOI: 10.1016/S0140-6736(03)13365-X
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321